{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:27Z","timestamp":1792427847301,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12640-019-00096-w","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T03:02:31Z","timestamp":1565665351000},"page":"239-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Epitope Mapping of Tetanus Toxin by Monoclonal Antibodies: Implication for Immunotherapy and Vaccine Design"],"prefix":"10.1007","volume":"37","author":[{"given":"Somayeh","family":"Ghotloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forough","family":"Golsaz-Shirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Jeddi-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-6365","authenticated-orcid":false,"given":"Fazel","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"96_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02124513","volume":"172","author":"G Ahnert-higer","year":"1983","unstructured":"Ahnert-higer G, Bizinni B, Goretzki K, Muller H, Volckers C, Habbermann E (1983) Monoclonal antibodies against tetanus toxin and toxoid. Med Microbiol Immunol 172:123\u2013135","journal-title":"Med Microbiol Immunol"},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/hyb.1992.11.165","volume":"11","author":"B Arunachalam","year":"1992","unstructured":"Arunachalam B, Ghosh S, Talwar GP, Raghupathy R (1992) A single human monoclonal antibody that confers total protection from tetanus. Hybridoma 11:165\u2013179","journal-title":"Hybridoma"},{"key":"96_CR3","doi-asserted-by":"publisher","first-page":"31386","DOI":"10.1074\/jbc.270.52.31386","volume":"270","author":"AC Ashton","year":"1995","unstructured":"Ashton AC, Li Y, Doussau F, Weller U, Dougan G, Poulain B, Dolly JO (1995) Tetanus toxin inhibits neuroexocytosis even when its Zn21-dependent protease activity is removed. J Biol Chem 270:31386\u201331390","journal-title":"J Biol Chem"},{"key":"96_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/tra.12197","volume":"15","author":"FC Blum","year":"2014","unstructured":"Blum FC, Tepp WH, Johnson EA, Barbieri JT (2014) Multiple domains of tetanus toxin direct entry into primary neurons. Traffic 15:1057\u20131065","journal-title":"Traffic"},{"key":"96_CR5","doi-asserted-by":"publisher","first-page":"26569","DOI":"10.1074\/jbc.M109.027391","volume":"284","author":"C Chen","year":"2009","unstructured":"Chen C, Fu Z, Kim JJ, Barbieri JT, Baldwin MR (2009) Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem 284:26569\u201326577","journal-title":"J Biol Chem"},{"key":"96_CR6","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/toxins7061854","volume":"7","author":"E Diamant","year":"2015","unstructured":"Diamant E, Torgeman A, Ozeri E, Zichel R (2015) Monoclonal antibody combinations that present synergistic neutralizing activity: a platform for next-generation anti-toxin drugs. Toxins (Basel) 7:1854\u20131881","journal-title":"Toxins (Basel)"},{"key":"96_CR7","volume-title":"European pharmacopoeia","author":"Council of Europe","year":"2010","unstructured":"Council of Europe (2010) European pharmacopoeia. Council Of Europe : European Directorate for the Quality of Medicines and Healthcare, Strasbourg"},{"key":"96_CR8","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1128\/IAI.55.11.2541-2545.1987","volume":"55","author":"NF Fairweather","year":"1987","unstructured":"Fairweather NF, Lyness VA, Maskell DJ (1987) Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect Immul 55:2541\u20132545","journal-title":"Infect Immul"},{"key":"96_CR9","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1128\/IAI.63.8.3218-3221.1995","volume":"63","author":"D Figueiredo","year":"1995","unstructured":"Figueiredo D, Turcotte C, Frankel G, Li Y, Dolly O, Wilkin G, Marriott D, Fairweather N, Dougan G (1995) Characterization of recombinant tetanus toxin derivatives suitable for vaccine development. Infect Immun 63:3218\u201332121","journal-title":"Infect Immun"},{"key":"96_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0264-410X(00)00115-8","volume":"19","author":"SP Fitzsimmons","year":"2000","unstructured":"Fitzsimmons SP, Clark KC, Wilkerson R, Shapiro MA (2000) Inhibition of tetanus toxin fragment C binding to ganglioside G(T1b) by monoclonal antibodies recognizing different epitopes. Vaccine 19:114\u2013121","journal-title":"Vaccine"},{"key":"96_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/hyb.1993.12.699","volume":"12","author":"B Gustafsson","year":"1993","unstructured":"Gustafsson B, Whitmore E, Tiru M (1993) Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C. Hybridoma 12:699\u2013708","journal-title":"Hybridoma"},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0021-9258(17)32815-6","volume":"252","author":"TB Helting","year":"1977","unstructured":"Helting TB, Zwisler O, Wiegandt H (1977) Structure of tetanus toxin. J Biol Chem 252:194\u2013198","journal-title":"J Biol Chem"},{"key":"96_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/BF00151713","volume":"6","author":"M Kamei","year":"1990","unstructured":"Kamei M, Hashizume S, Sugimoto N, Ozutsumi K, Matsuda M (1990) Establishment of stable mouse\/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity. Eur J Epidemiol 6:386\u2013397","journal-title":"Eur J Epidemiol"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1242\/jcs.112.16.2715","volume":"112","author":"G Lalli","year":"1999","unstructured":"Lalli G, Herreros J, Osborne SL, Montecucco C, Rossetto O, Schiavo G (1999) Functional characterisation of tetanus and botulinum neurotoxins binding domains. J Cell Sci 112:2715\u201327124","journal-title":"J Cell Sci"},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.151.1.466","volume":"151","author":"AB Lang","year":"1993","unstructured":"Lang AB, Cryz SJ Jr, Schurch U, Ganss MT, Bruderer U (1993) Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin. J Immunol 151:466\u2013472","journal-title":"J Immunol"},{"key":"96_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/IAI.49.1.111-115.1985","volume":"49","author":"CS Lin","year":"1985","unstructured":"Lin CS, Habig WH, Hardegree MC (1985) Antibodies against the light chain of tetanus toxin in human sera. Infect Immul 49:111\u2013115","journal-title":"Infect Immul"},{"key":"96_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.toxicon.2015.06.025","volume":"103","author":"I Lukic","year":"2015","unstructured":"Lukic I, Marinkovic E, Filipovic A, Krnjaja O, Kosanovic D, Inic-Kanada A, Stojanovic M (2015) Key protection factors against tetanus: anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction. Toxicon 103:135\u2013144","journal-title":"Toxicon"},{"key":"96_CR18","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1016\/j.vaccine.2012.08.002","volume":"30","author":"P Luo","year":"2012","unstructured":"Luo P, Qin L, Mao X, Chen L, Yu S, Li Q, Liu W, Zhang W, Gu J, Zou Q (2012) Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design. Vaccine 30:6449\u20136455","journal-title":"Vaccine"},{"key":"96_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02427384","volume":"8","author":"M Matsuda","year":"1992","unstructured":"Matsuda M, Kamei M, Sugimoto N, Ma Y, Hashizume S (1992) Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies. Eur J Epidemiol 8:1\u20138","journal-title":"Eur J Epidemiol"},{"key":"96_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1098\/rstb.1999.0377","volume":"354","author":"R Pellizzari","year":"1999","unstructured":"Pellizzari R, Rossetto O, Schiavo G, Montecucco C (1999) Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond Ser B Biol Sci 354:259\u2013268","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"96_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.acthis.2011.09.001","volume":"114","author":"V Petrusic","year":"2012","unstructured":"Petrusic V, Zivkovic I, Stojanovic M, Stojicevic I, Marinkovic E, Dimitrijevic L (2012) Production, characterization and applications of a tetanus toxin specific monoclonal antibody T-62. Acta Histochem 114:480\u2013486","journal-title":"Acta Histochem"},{"key":"96_CR22","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3390\/toxins6051512","volume":"6","author":"SH Pincus","year":"2014","unstructured":"Pincus SH, Das A, Song K, Maresh GA, Corti M, Berry J (2014) Role of Fc in antibody-mediated protection from ricin toxin. Toxins (Basel) 6:1512\u20131525","journal-title":"Toxins (Basel)"},{"key":"96_CR23","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.molimm.2010.02.020","volume":"47","author":"N Scott","year":"2010","unstructured":"Scott N, Qazi O, Wright MJ, Fairweather NF, Deonarain MP (2010) Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding. Mol Immunol 47:1931\u20131941","journal-title":"Mol Immunol"},{"key":"96_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0198-8859(87)90042-5","volume":"19","author":"D Scrivner","year":"1987","unstructured":"Scrivner D, Kristof S, Rodey G (1987) Human T4 + T-lymphocyte clones specific for the B fragment of tetanus toxin. Hum Immunol 19:245\u2013254","journal-title":"Hum Immunol"},{"key":"96_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/IAI.43.2.710-714.1984","volume":"43","author":"AJ Sheppard","year":"1984","unstructured":"Sheppard AJ, Cussell D, Hughes M (1984) Production and characterization of monoclonal antibodies to tetanus toxin. Infect Immun 43:710\u2013714","journal-title":"Infect Immun"},{"key":"96_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0140-6736(14)60236-1","volume":"385","author":"CL Thwaites","year":"2015","unstructured":"Thwaites CL, Beeching NJ, Newton CR (2015) Maternal and neonatal tetanus. Lancet 385:362\u2013370","journal-title":"Lancet"},{"key":"96_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1128\/IAI.45.3.604-609.1984","volume":"45","author":"WA Volk","year":"1984","unstructured":"Volk WA, Bizzini B, Snyder RM, Bernhard E, Wagner RR (1984) Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. Infect Immun 45:604\u2013609","journal-title":"Infect Immun"},{"key":"96_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4161\/hv.26769","volume":"10","author":"M Yousefi","year":"2014","unstructured":"Yousefi M, Khosravi-Eghbal R, Reza Mahmoudi A, Jeddi-Tehrani M, Rabbani H, Shokri F (2014a) Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies. Hum Vaccin Immunother 10:344\u2013351","journal-title":"Hum Vaccin Immunother"},{"key":"96_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/1547691X.2013.763872","volume":"11","author":"M Yousefi","year":"2014","unstructured":"Yousefi M, Tahmasebi F, Younesi V, Razavi A, Khoshnoodi J, Bayat AA, Abbasi E, Rabbani H, Jeddi-tehrani M, Shokri F (2014b) Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C. J Immunotoxicol 11:28\u201334","journal-title":"J Immunotoxicol"},{"key":"96_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/1547691X.2015.1046572","volume":"13","author":"M Yousefi","year":"2016","unstructured":"Yousefi M, Younesi V, Bayat AA, Jadidi-Niaragh F, Abbasi E, Razavi A, Khosravi-eghbal R, Asgarian-omaran H, Shokri F (2016) Comparative human and mouse antibody responses against tetanus toxin at clonal level. J Immunotoxicol 13:243\u2013248","journal-title":"J Immunotoxicol"},{"key":"96_CR31","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1016\/j.vaccine.2011.06.039","volume":"29","author":"YZ Yu","year":"2011","unstructured":"Yu YZ, Gong ZW, Ma Y, Zhang SM, Zhu HQ, Wang WB, Du Y, Wang S, Yu WY, Sun ZW (2011) Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate. Vaccine 29:5978\u20135985","journal-title":"Vaccine"},{"key":"96_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/hyb.1986.5.21","volume":"5","author":"HW Ziegler-Heitbrock","year":"1986","unstructured":"Ziegler-Heitbrock HW, Reiter C, Trenkmann J, Futterer A, Riethmuller G (1986) Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule. Hybridoma 5:21\u201331","journal-title":"Hybridoma"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00096-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T21:29:36Z","timestamp":1695072576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00096-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00096-w","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"20 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}